Welcome to our dedicated page for Liquidia Corporation news (Ticker: $LQDA), a resource for investors and traders seeking the latest updates and insights on Liquidia Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Liquidia Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Liquidia Corporation's position in the market.
Liquidia (NASDAQ: LQDA) will present data on the investigational use of L606 (liposomal treprostinil) inhalation suspension at the ATS 2024 International Conference. The company aims to demonstrate the safety and tolerability of L606 in patients with PAH and PH-ILD through a Phase 3, 2-part, open-label, multicenter study. The presentation will be on May 22, 2024, in San Diego, California. Liquidia plans to initiate a global pivotal efficacy trial later this year based on the study's positive results.
Liquidia (NASDAQ: LQDA) will be presenting at the BofA Securities Health Care Conference 2024, where Michael Kaseta, the COO and CFO, will update investors on the company's business. The presentation will take place on May 14, 2024, at 5:00 p.m. PT in Las Vegas, Nevada. A webcast of the event will be accessible on Liquidia's website, with a recorded version available for 30 days post-event.
Liquidia (NASDAQ: LQDA) will report its first quarter 2024 financial results on May 14, 2024. A live webcast will be hosted at 8:30 a.m. Eastern Time to discuss financial results and provide a corporate update. The webcast will be available on Liquidia's website. A rebroadcast will be archived for one year.